Determination of CYP2C19 Polymorphism, Side Effects, and Medication Adherence in Patients Who have Utilized Selective Serotonin Reuptake Inhibitors


Creative Commons License

Deniz S., SANCAR M., OKUYAN B., ATA P., Ozakpinar O. B. , TALAS A., et al.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, cilt.26, ss.152-160, 2016 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 26 Konu: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5455/bcp.20151003060610
  • Dergi Adı: KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
  • Sayfa Sayısı: ss.152-160

Özet

Objective: The aim of this study is to determine relationship of cytochrome P-450 2C19 (CYP2C19) enzymes polymorphism, side effects, and medication adherence in patients who have been diagnosed with major depression and have utilized selective serotonin reuptake inhibitors.